Amarin (AMRN) Vascepa Growth Continues; Sees Limited Negative Read-Through from Merck's HPS2-THRIVE

Go back to Amarin (AMRN) Vascepa Growth Continues; Sees Limited Negative Read-Through from Merck's HPS2-THRIVE
Amarin Corp Plc (NASDAQ: AMRN) Delayed: 14.29 +0.16 (1.13%)
Previous Close $14.13    52 Week High $3.65 
Open $14.29    52 Week Low $1.24 
Day High $14.55    P/E N/A 
Day Low $14.09    EPS $0.00 
Volume 30,884